ImmunoBrain Checkpoint appoints Dr. Sanjay Keswani as CEO
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The ANDA was filed as 'First to File' submission on NCE-1 date.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
She joins Enveda from Gilead Sciences
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Subscribe To Our Newsletter & Stay Updated